Catecholamine prodrugs for use in the treatment of parkinson’s disease
US-2025381208-A1 · Dec 18, 2025 · US
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D215/00 |
| Official title | Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems |
| Display label | Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems |
| Total patents | 49 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 5 |
| 2019 | 10 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 3 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Production method for t cells or nk cells, medium for culturing t cells or nk cells, method for culturing t cells or nk cells, method for maintaining undifferentiated state of undifferentiated t cells, and growth-accelerating agent for t cells or nk cells
US-2025129075-A1 · Apr 24, 2025 · US
Catecholamine prodrugs for use in the treatment of Parkinson's disease
US-12226428-B2 · Feb 18, 2025 · US
PAPD5 inhibitors and methods of use thereof
US-12171755-B2 · Dec 24, 2024 · US
Production method for T cells or NK cells, medium for culturing T cells or NK cells, method for culturing T cells or NK cells, method for maintaining undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells
US-12168781-B2 · Dec 17, 2024 · US
Catecholamine prodrugs for use in the treatment of parkinson’s disease
US-2024156851-A1 · May 16, 2024 · US
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
US-11951212-B2 · Apr 9, 2024 · US
Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof
US-11873292-B2 · Jan 16, 2024 · US
Catecholamine prodrugs for use in the treatment of parkinson's disease
US-11707476-B2 · Jul 25, 2023 · US
New catecholamine prodrugs for use in the treatment of parkinson's disease
US-2022257623-A1 · Aug 18, 2022 · US
Production method for t cells or nk cells, medium for culturing t cells or nk cells, method for culturing t cells or nk cells, method for maintaining undifferentiated state of undifferentiated t cells, and growth-accelerating agent for t cells or nk cells
US-2022017867-A1 · Jan 20, 2022 · US
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
US-2021308053-A1 · Oct 7, 2021 · US
Catecholamine prodrugs for use in the treatment of Parkinson's disease
US-11110110-B2 · Sep 7, 2021 · US
Solid state forms of Lenvatinib Mesylate
US-11084791-B2 · Aug 10, 2021 · US
Papd5 inhibitors and methods of use thereof
US-2021177827-A1 · Jun 17, 2021 · US
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
US-10980746-B2 · Apr 20, 2021 · US
Catecholamine prodrugs for use in the treatment of parkinson's disease
US-2020338102-A1 · Oct 29, 2020 · US
Catecholamine prodrugs for use in the treatment of Parkinson's disease
US-10729710-B2 · Aug 4, 2020 · US
Prodrugs of Nh-acidic compounds
US-10723728-B2 · Jul 28, 2020 · US
Prodrugs of nh-acidic compounds
US-2019367501-A1 · Dec 5, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D215/00?
- CPC C07D215/00 is the Cooperative Patent Classification code for “Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems.”
- How many patents are filed under CPC C07D215/00 (Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems)?
- Our database includes 49 publications tagged with this CPC code.
- Is patent activity under CPC C07D215/00 growing?
- Publication counts under this code: 5 in 2024 vs 3 in 2025 (latest complete years).